Clinical trial · Observational
Remote Rapid Onsite Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA)
Remote Rapid On-site Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Rapid On-Site Evaluation (ROSE) of cytology FNA samples performed by a Pathologist or Biomedical Scientist is a real time morphological assessment of the sample in the clinical setting with the aim of acquiring all the diagnostic material in one appointment resulting in reduction in costs, improved patient care and reduced referral to treatment time. It is not practical or possible for the ROSE team to be present in every location where an FNA is performed. Telecytology (TC) or remote ROSE is a digital form of ROSE which allows a biomedical scientist or pathologist working in a remote laboratory to review the cytology slides in real time, using microscope images fed from the location where the FNA procedure is being performed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Neoplasms | Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Olympus Cellsens software | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Laboratory testing
- description
- Slides reviewed in the laboratory to test the platform for suitability prior to involving patients
- interventionNames
- Device: Olympus Cellsens software
- label
- Remote ROSE on the same site as the laboratory
- description
- The next phase will involve remote ROSE being performed on the same site as the laboratory in an ultrasound room located on the Royal Cornwall Hospitals Truro site.
- interventionNames
- Device: Olympus Cellsens software
- label
- Remote ROSE at a site external to the laboratory
- description
- Phase 3 will involved remote ROSE being performed on a different site to the laboratory. The ultrasound room at The Royal Cornwall Hospital's Camborne and Redruth site.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Male and female participants \> 18-90 years of age * Participants attending for an ultrasound guided fine needle aspiration of lesions in the head and neck and supraclavicular fossa nodes. * All ethnicity or socioeconomic grouping that require an US FNA at RCHT over the 12-month study period. * Able and willing to consent to the study Exclusion Criteria: * Anyone \<18 years of age * Patients that do not require an FNA after the initial ultrasound * Any participants considered vulnerable will not be included in the study. * This study involves testing the concept of remote ROSE rather than direct impact on patient care needs related to ethical of communication issues. For practical considerations and to prevent unnecessary anxiety for patients who are unable to read the information sheets and provide consent, these patients will not be included in the study. * Unable or unwilling to consent to the study
References
Publications (0)
Data not yet available